Elliot Epner

4.8k total citations · 1 hit paper
68 papers, 3.8k citations indexed

About

Elliot Epner is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Elliot Epner has authored 68 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 25 papers in Oncology and 23 papers in Pathology and Forensic Medicine. Recurrent topics in Elliot Epner's work include Lymphoma Diagnosis and Treatment (23 papers), Viral-associated cancers and disorders (18 papers) and Chronic Lymphocytic Leukemia Research (17 papers). Elliot Epner is often cited by papers focused on Lymphoma Diagnosis and Treatment (23 papers), Viral-associated cancers and disorders (18 papers) and Chronic Lymphocytic Leukemia Research (17 papers). Elliot Epner collaborates with scholars based in United States, Germany and Italy. Elliot Epner's co-authors include Mark Groudine, William C. Forrester, Steven Fiering, Tariq Enver, Agnes Telling, Richard I. Fisher, Andreas Reik, Steven H. Bernstein, Daniel Cimbora and Chul Geun Kim and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Elliot Epner

66 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

2006 553 citations Richard I. Fisher, Steven H. Bernstein et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elliot Epner United States	29	2.5k	886	879	778	627	68	3.8k
Norihiko Kawamata Japan	38	2.2k 0.9×	610 0.7×	745 0.8×	1.4k 1.7×	382 0.6×	96	4.0k
Doris Steinemann Germany	31	1.6k 0.7×	344 0.4×	407 0.5×	551 0.7×	531 0.8×	127	2.8k
Syed M. Jalal United States	28	1.3k 0.5×	519 0.6×	317 0.4×	310 0.4×	1.0k 1.6×	71	2.6k
Lucio H. Castilla United States	23	2.2k 0.9×	790 0.9×	162 0.2×	317 0.4×	651 1.0×	46	3.2k
Blanca Scheijen Netherlands	24	1.5k 0.6×	282 0.3×	374 0.4×	615 0.8×	178 0.3×	53	2.6k
Genta Nagae Japan	24	2.6k 1.1×	225 0.3×	281 0.3×	468 0.6×	386 0.6×	48	3.4k
Arito Yamane Japan	22	3.4k 1.4×	271 0.3×	267 0.3×	817 1.1×	318 0.5×	50	4.5k
Mats Ehinger Sweden	30	1.5k 0.6×	761 0.9×	558 0.6×	847 1.1×	194 0.3×	86	3.2k
Ellen van Drunen Netherlands	27	2.5k 1.0×	163 0.2×	182 0.2×	960 1.2×	529 0.8×	42	3.7k
G M Brodeur United States	26	2.8k 1.1×	625 0.7×	150 0.2×	1.1k 1.4×	669 1.1×	46	5.9k

Countries citing papers authored by Elliot Epner

Since Specialization

Citations

This map shows the geographic impact of Elliot Epner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elliot Epner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elliot Epner more than expected).

Fields of papers citing papers by Elliot Epner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elliot Epner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elliot Epner. The network helps show where Elliot Epner may publish in the future.

Co-authorship network of co-authors of Elliot Epner

This figure shows the co-authorship network connecting the top 25 collaborators of Elliot Epner. A scholar is included among the top collaborators of Elliot Epner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elliot Epner. Elliot Epner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spurgeon, Stephen E., Kamal Sharma, David F. Claxton, et al.. (2019). Phase 1–2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B‐cell non‐Hodgkin lymphoma and previously untreated mantle cell lymphoma. British Journal of Haematology. 186(6). 845–854. 19 indexed citations

Zhao, Jianzhi, et al.. (2019). Mantle cell lymphoma and its management: where are we now?. Experimental Hematology and Oncology. 8(1). 2–2. 28 indexed citations

Epner, Elliot, et al.. (2016). Combination epigenetic and immunotherapy overcomes resistance to monoclonal antibodies in hematologic malignancies: A new therapeutic approach. Experimental Hematology. 44(3). 157–160. 3 indexed citations

Bernstein, Steven H., Elliot Epner, Joseph M. Unger, et al.. (2013). A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213. Annals of Oncology. 24(6). 1587–1593. 86 indexed citations

Zhu, Junjia, W. Christopher Ehmann, Elliot Epner, et al.. (2012). G-CSF mobilized vs conventional donor lymphocytes for therapy of relapse or incomplete engraftment after allogeneic hematopoietic transplantation. Bone Marrow Transplantation. 48(3). 357–362. 18 indexed citations

Hasanali, Zainul S., Kamal Sharma, & Elliot Epner. (2012). Flipping the cyclin D1 switch in mantle cell lymphoma. Best Practice & Research Clinical Haematology. 25(2). 143–152. 11 indexed citations

Ghai, Vikas, et al.. (2012). Current Approaches to Epigenetic Therapy for the Treatment of Mantle Cell Lymphoma. Advances in experimental medicine and biology. 779. 257–266. 5 indexed citations

Talamo, Giampaolo, Umar Farooq, Maurizio Zangari, et al.. (2010). Beyond the CRAB Symptoms: A Study of Presenting Clinical Manifestations of Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 10(6). 464–468. 61 indexed citations

Goy, André, Steven H. Bernstein, Brad S. Kahl, et al.. (2008). Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study. Annals of Oncology. 20(3). 520–525. 243 indexed citations

10.

Laport, Ginna G., Brenda M. Sandmaier, Barry E. Storer, et al.. (2008). Reduced-Intensity Conditioning followed by Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Myelodysplastic Syndrome and Myeloproliferative Disorders. Biology of Blood and Marrow Transplantation. 14(2). 246–255. 97 indexed citations

11.

Cohen‐Barak, Orit, Nobuko Hagiwara, Paul D. Kingsley, et al.. (2006). Sox6 Directly Silences Epsilon Globin Expression in Definitive Erythropoiesis. PLoS Genetics. 2(2). e14–e14. 95 indexed citations

12.

Wang, Jin, et al.. (2005). Targeted Deletion of the Chicken β-Globin Regulatory Elements Reveals a Cooperative Gene Silencing Activity. Journal of Biological Chemistry. 280(24). 23340–23348. 3 indexed citations

13.

Kerbauy, Fábio R., Rainer Storb, Ute Hegenbart, et al.. (2005). Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML. Leukemia. 19(6). 990–997. 37 indexed citations

14.

Hegenbart, Ute, Dietger Niederwieser, Stephen J. Forman, et al.. (2003). Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. Biology of Blood and Marrow Transplantation. 9(11). 689–697. 37 indexed citations

15.

Reik, Andreas, Agnes Telling, Galynn Zitnik, et al.. (1998). The Locus Control Region Is Necessary for Gene Expression in the Human β-Globin Locus but Not the Maintenance of an Open Chromatin Structure in Erythroid Cells. Molecular and Cellular Biology. 18(10). 5992–6000. 143 indexed citations

16.

Epner, Elliot, Andreas Reik, Daniel Cimbora, et al.. (1998). The β-Globin LCR Is Not Necessary for an Open Chromatin Structure or Developmentally Regulated Transcription of the Native Mouse β-Globin Locus. Molecular Cell. 2(4). 447–455. 170 indexed citations

17.

Ley, Timothy J., Bruce A. Hug, Steven Fiering, et al.. (1998). Reduced β‐Globin Gene Expression in Adult Mice Containing Deletions of Locus Control Region 5′ HS‐2 or 5′ HS‐3^a. Annals of the New York Academy of Sciences. 850(1). 45–53. 11 indexed citations

18.

Dieken, Ellen S., Elliot Epner, Steven Fiering, R. E. K. Fournier, & Mark Groudine. (1996). Efficient modification of human chromosomal alleles using recombination-proficient chicken/human microcell hybrids. Nature Genetics. 12(2). 174–182. 81 indexed citations

19.

Fiering, Steven, Chul Geun Kim, Elliot Epner, & Mark Groudine. (1993). An "in-out" strategy using gene targeting and FLP recombinase for the functional dissection of complex DNA regulatory elements: analysis of the beta-globin locus control region.. Proceedings of the National Academy of Sciences. 90(18). 8469–8473. 93 indexed citations

20.

Epner, Elliot, Chul Geun Kim, & Mark Groudine. (1992). What does the locus control region control?. Current Biology. 2(5). 262–264. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact